Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 151
News
News | 05 December 2021

Lupin and Biomm tie-up for pegfilgrastim in Brazil

Lupin had earlier received the U.S. FDA acceptance of the Biologics License Application (BLA) for Its proposed biosimilar

News
News | 05 December 2021

Eris signs JV with MJ Biopharm to supply insulin in India

MJ will be paid a one-time lumpsum licence fee of Rs 15 crore

News
News | 05 December 2021

Motherhood Hospitals opens second center in Pune

The first hospital in Kharadi launched three years ago has made a significant difference to women and children's health

News
News | 05 December 2021

Monthly production capacity of Covishield and Covaxin touches 90% : Govt

Serum has a capacity of 250-275 million whereas Bharat Biotech has a capacity of 50-60 million

News
News | 03 December 2021

Novartis showcases its attractive growth pipeline

Focused medicines company delivering strong operational performance. Building depth in five core therapeutic areas, strength in technology platforms, and a balanced geographic footprint

News
News | 03 December 2021

North America accounts for 50 % of generic pharma market

Going forward, the fastest-growing regions in the generic pharmaceuticals market will be South America and the Middle East, where growth will be at CAGRs of 10.1% and 9.4% respectively

News
News | 03 December 2021

Booster dose for those above 40

The recommendation was made by the Indian SARS-CoV-2 Genomics Sequencing Consortium (INSACOG), a network of national testing labs set up by the government to monitor genomic variations of Covid-19

News
News | 02 December 2021

Serum seeks DCGI approval for booster dose in India

The UK’s Medicine and Healthcare products Regulatory Agency has already approved the booster dose of AstraZenenca’s Covid-19 vaccine, which is administered in India

News
News | 02 December 2021

Molnupiravir, a step closer to approval in the fight against Covid-19

The U.S. FDA advisory committee voted 13-10 in favour of the oral antiviral medicine

News
News | 02 December 2021

Premas Biotech and Oravax to test their vaccine candidate against Omicron

Oravax's vaccine technology is highly scalable for manufacturing and is easily transferable for wide scale logistical distribution, as there is no need for freezer storage

News
News | 02 December 2021

Amrutanjan Health Care opens first store in Chennai

The offline store launch will complement the E-commerce website in building a rich consumer shopping experience

News
News | 02 December 2021

Sanofi to acquire Origimm Biotechnology to treat acne with vaccine

Transaction adds to Sanofi pipeline a potential first-in-class vaccine candidate in acne vulgaris, a condition affecting millions of people worldwide

News
News | 02 December 2021

ZyCoV-D to be initially administered in seven states

The three doses of ZyCoV-D are to be administered 28 days apart. The vaccine was given emergency use authorisation (EUA) by the Indian drug regulator on August 20

News
News | 30 November 2021

DaVita research indicates effectiveness of mRNA vaccine in dialysis patients

Researchers observed that the Pfizer/BioNTech and Moderna vaccines were 78% and 73% effective in preventing Covid-19 infections, respectively

News
News | 30 November 2021

Conference highlights opportunities in the nursing profession

This collaborative nursing conference generated a positive dialogue on how the healthcare space of nursing has evolved in the past year

News
News | 30 November 2021

Lupin launches learning platform for medical students

Sciflix is a special Initiative by Lupin to assist future pulmonologists in staying abreast of the latest medical advances relevant to their speciality

News
News | 30 November 2021

RDIF believes that Sputnik vaccines can neutralise Omicron

According to the Russian Direct Investment Fund (RDIF), the Russian Sputnik V and Sputnik Light vaccines have proven to be highly effective against all variants of SARC-Cov-2

News
News | 30 November 2021

UAE authorises Sputnik Light vaccine as universal booster

Booster dose is available to all residents aged 18+ and can be applied six months after the second dose of any other vaccine administered in UAE

News
News | 29 November 2021

Bharat Biotech commences export of Covaxin

It’s a two-dose vaccine administered 28 days apart

News
News | 27 November 2021

Fifty-five manufacturers selected for Pharma PLI sector

The appraisal of the applications has been carried out based on the ranking methodology laid down in the operational guidelines of the Scheme

Startup

Digitization